Research Article - (2023) Volume 6, Issue 1
Chickenpox in pregnancy
Received Date: Jul 27, 2023 / Accepted Date: Aug 01, 2023 / Published Date: Aug 29, 2023
Copyright: ©©2023 Rehan Haider. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Citation: Haider, R. (2023). Chickenpox in pregnancy. Toxi App Pharma Insights Research, 6(1), 09-14.
Abstract
Varicella, the number one contamination with varicella-zoster virus (VZV; human herpes virus) in pregnancy, might also cause maternal mortality or extreme morbidity. It may also be the cause of fetal varicella syndrome (FVS) and varicella contamination in new children, which incorporates congenital varicella syndrome (CVS) and neonatal varicella. This guiding principle addresses the role of varicella vaccination in women of reproductive ages. The rule also assesses evidence concerning the maternal and fetal risks of VZV contamination in pregnancy and whether these headaches may be prevented or changed beneficially with the aid of the management of varicella-zoster immunoglobulin (VZIG) or with the aid of a remedy for infected people with acyclovir. This fact should manual the prudent use of VZIG, which is made of the plasma of human blood donors and is consequently a restricted and costly aid. The control of neonates is outdoor the scope of this tenet. Guidance on neonatal publicity and disorder is to be had from other sources [1-2]
Keywords
congenital varicella syndrome, neonatal contamination, pregnancy, varicella
Introduction
VZV is a DNA virus of the herpes circle of relatives that is quite contagious and transmitted with the aid of breathing droplets and by direct private contact with vesicle fluid through fomites (e.g., skin cells, hair, apparel, and bedding). The primary infection is characterized by fever, malaise, and a pruritic rash that develops into maculopapular crops, which end up vesicular and crust- over before restoration. The incubation duration is between 1 and 3 weeks, and the sickness is infectious 48 h earlier than the rash seems and continues to be infectious until the vesicles crust over. The vesicles generally crust within five days. Chickenpox (or primary VZV infection) is a common childhood disorder that causes slight contamination. Over 90% of people over 15 years of age in England and Wales are seropositive for VZV immunoglobulin G (IgG) antibodies. {3} studies of pregnant girls in Spain and France discovered that 96.1% and 98. % respectively were immune to varicella [4-5]. Because this, even though contact with chickenpox is not unusual in being pregnant, mainly in women with young children, primary VZV contamination in being pregnant is unusual; it's far estimated to complicate three in every one thousand pregnancies [6]. Ladies from tropical and subtropical areas are much more likely to be seronegative for VZV IgG and are consequently greater liable to the development of chickenpox in pregnancy [7].
Following the number [1] contamination, the virus stays dormant in sensory nerve root ganglia, however, can be reactivated to reason vesicular erythematous pores and skin rash in a dermatomal distribution referred to as herpes zoster, additionally known as ‘zoster’ or ‘shingles.’ The danger of acquiring infection from an immunocompetent individual with herpeszoster on non-uncovered websites (e.g., thoracolumbar) is far off but can arise.8 but, disseminated zoster or exposed zoster (e.g., ophthalmic) in any individual or localized zoster in an immuno suppressed patient have to be taken into consideration to be infectious, as the viral dropping may be greater.
The records have to be shown with unique respect to the form of VZV contamination [II], the timing of the exposure [III], and the closeness and length of contact. Chickenpox is infectious for two days before the advent of the rash and the length of the contamination, while the skin lesions are lively. It ceases to be infectious, but the lesions have crusted over. Herpes zoster (shingles) additionally poses a danger if it's miles disseminated or it occurs in an exposed location of the frame (e.g. ophthalmic shingles) or in an immuno-compromised individual where viral shedding can be more. The risk of infection following touch with herpes zoster that isn't in an exposed vicinity (e.g. thoracolumbar shingles) is far off but can arise [8].
Full-size contact is defined as touch in the same room for 15 min or more, face-to-face touch, or touch in the setting of a large open ward. The susceptibility of the girl should be determined by eliciting a history of chickenpox or shingles. If there is a definite history of chickenpox, it is reasonable to anticipate that the patient is proof of varicella contamination. If the girl’s immunity to chickenpox is unknown, and if there is any doubt about the preceding infection, or if there are no previous records of chickenpox or shingles, the serum must be tested for VZV IgG. This could normally be performed within 24–48 h and often within some hours if the laboratory can enter serum saved from an antenatal booking blood pattern. As a minimum 80% of ladies examined can have VZV IgG and can be reassured [9].
If the pregnant lady is not immune to VZV and she has had significant publicity to chickenpox or shingles, she ought to be presented VZIG as quickly as feasible or on the very modern within 10 days of the publicity (within the case of non-stop family exposures, within 10 days of the appearance of the rash in the index case).{10} VZIG is indicated after good-sized publicity to VZV at any level of being pregnant, and postnatally if the start takes place within 10 days of publicity [11]. If the immune reputation of the girl is unknown, the management of VZIG can be delayed until serology results are achieved (if the laboratory turnaround time is 24–48 hours).
The reason for the management of VZIG is that it could save you or attenuate chickenpox in non-immune individuals1 and it may reduce the hazard of the development of FVS [12].
In an observational take a look at of 212 seronegative girls who received the ideal dose of VZIG, either intramuscular or intravenous, within 10 days of substantial exposure to chickenpox, half of the ladies advanced both every day or an attenuated form of chickenpox, and a further five% had a sub clinical infection [13].
A recent meta-analysis of three case series showed that 0/142 infants of women who developed varicella during pregnancy notwithstanding receiving VZIG suffered from FVS, compared with 14/498 (2.8%) among those who did not receive VZIG. but, a case collection of 106 ladies who advanced chickenpox inside the first 20 weeks of pregnancy covered 5 women who had been dealt with VZIG, considered one of whom introduced an infant with congenital varicella syndrome [14].
This evidence supports the use of VZIG to prevent FVS but is based entirely on observational information and can be related to reporting bias. The damaging results of VZIG encompass pain and erythema on the injection website. The chance of anaphylaxis is cited as much less than zero. 1% with the aid of facilities for disorder manipulation and prevention [15] and ‘very rare’ with the aid of Public Fitness England. Patients with hypo gamma globinaemia and immunoglobulin a antibodies who are already receiving alternative treatment with immunoglobulins do not require VZIG and are at an accelerated risk of anaphylactic reactions. No case of blood- borne contamination has been reported with the use of ZIGGY- inclined women who have touched chickenpox or shingles (regardless of whether they have received VZIG) and need to be asked to notify their health practitioner or midwife early if a rash develops. Notwithstanding the blessings of VZIG in preventing or attenuating diseases, pregnant women can also end up seriously unwell. Varicella contamination is much less common in adults than in youngsters; however, its miles are associated with increased morbidity, particularly pneumonia, hepatitis, and encephalitis. As these days as the 1990s, chickenpox resulted in the deaths of 25 humans consistent a year in England and Wales; eighty% of those deaths came about in adults [16].
The incidence of pneumonia complicating varicella in pregnancy has been reported to be 10– 14%, 28 but these charges are primarily based on a small case series. In a chain of 347 instances of varicella infection during pregnancy, 5% of the women developed pneumonia [17].
The general mortality rate in the case of varicella pneumonia in pregnancy posted within the English language literature in the pre-antiviral technology was 10/28 (36%), which may additionally replicate booklet bias.30 more current case series record mortality fees of zero–14%, with enhancements attributed to antiviral therapy and advanced in-depth care.,31,32 Between 1985 and 1999, there were nine indirect maternal deaths and one past due maternal death suggested inside the United Kingdom from headaches of maternal varicella infection,33–37 suggesting a low case fatality fee. There has been no pronounced maternal death from varicella within the subsequent exclusive inquiries.38–40 Pneumonia can be more excessive in a later gestational period due to the effects of the gravid uterus on breathing characteristics [18].
Acyclovir is an artificial nucleoside analog that inhibits the replication of the varicella-zoster virus. A randomized controlled trial showed that acyclovir administered orally (800 mg, five instances per day for 7 days) reduced the period of fever and symptomatology of varicella infection in immunocompetent adults if started within 24 hours of growing the rash in comparison to placebo. This randomized managed trial did not have sufficient energy to comment on the effect of early oral acyclovir on the serious complications of chickenpox [19].
Information is collected to suggest that there's no boom within the threat of most important fetal malformation with acyclovir publicity in being pregnant [20–22].
A Danish registry-primarily based cohort study of 837795 stay births between 1996 and 200843 stated the pregnancy outcome in 1804 pregnancies uncovered to acyclovir, Val acyclovir, or famciclovir within the first trimester. The rate of predominant start defects in the uncovered group was 2.2%, compared to 2.4% in the unexposed group (adjusted occurrence odds ratio 0.89, 95% CI zero. 65–1.22).
The most commonly used antiviral drug was acyclovir. Among 1561 pregnancies exposed to acyclovir, 32 toddlers (2.0%) had a primary anomaly compared to 2.4% of the controls. They have looked at is confined in that it is based entirely on facts of prescriptions that have been stuffed, and this is oblique evidence of publicity. Similarly, look-at no longer has the power to exclude the increased chance of any individual defect. While some multidisciplinary publications [23–25].
Suggest the use of antiviral retailers in all pregnant women with chickenpox, the Swiss and Canadian countrywide hint dissent [26-27]. The United Kingdom Advisory Institution on Chickenpox recommends oral acyclovir for pregnant women with chickenpox if they present within 24 hours of the onset of the rash and if they are more than 20 weeks of gestation. Therefore, the use of acyclovir for 20 weeks should also be considered [28]. Pointers are unanimous; however, it is recommended that intravenous acyclovir be administered in cases of extreme maternal infections [29–34].
VZIG is usually recommended for put-up exposure prophylaxis and is not the best treatment for patients with medical chickenpox. This advice is primarily based on the opinions of specialists and displays conventional knowledge of the way VZIG works. Respiration signs and neurological symptoms such as photo phobia, seizures or drowsiness, a hemorrhagic rash or bleeding, or a dense rash with or without mucosal lesions are indicative of potentially life-threatening chickenpox and are indicators for referral to a sanatorium with intensive care access. If the girl smokes cigarettes, has continual lung disorder, is immuno suppressed (together with those who have taken systemic corticosteroids in the previous 3 months), or is in the 2nd half of pregnancy, a hospital evaluation ought to be taken into consideration even inside the absence of headaches depending on the severity of the maternal condition, a respiratory health practitioner and intensive care specialist may be involved in per partum care. Delivery during the viraemic duration, while the chickenpox vesicles are energetic, can be extremely unsafe. Transport might also precipitate maternal hemorrhage and/or coagulopathy because of Thrombocytopenia or hepatitis. there is additionally a high hazard of varicella contamination in newborns with widespread morbidity and mortality{35,36} Supportive remedy and intravenous acyclovir are therefore proper, permitting resolution of the rash, immune recovery, and switch of protecting antibodies from the mom to the fetus. Preferably, not less than 7 days must elapse between the onset of the rash and delivery. But, shipping may be required to facilitate assisted airflow in instances wherein varicella pneumonia is complicated using breathing failure. No evidence is available to determine the gold standard anesthesia technique for women requiring shipping by utilizing a cesarean section. General anesthesia may exacerbate breathing compromise associated with varicella pneumonia. There may be a theoretical risk of transmitting the varicella-zoster virus from the pores and skin lesions to the principal apprehensive machine via spinal anesthesia. Epidural anesthesia may be safer than spinal anesthesia because the dura does not always penetrate; however, the larger needle required for epidural anesthesia carries the theoretical risk of shifting an extra viral load from the skin to the epidural space. A domain free of cutaneous lesions must be chosen for needle placement [37].
Spontaneous miscarriage does not appear to increase if chickenpox occurs during the first trimester. FVS is characterized by one or more of the following: pores and skin scarring in a dermatomal distribution, eye defects (microphthalmia, chorioretinitis, or cataracts), hypoplasia of the limbs, and neurological abnormalities (microcephaly, cortical atrophy, intellectual retardation, or dysfunction of bowel and bladder sphincters) [38]. It no longer occurs at the time of initial fetal infection but outcomes from a subsequent herpes zoster reactivation in utero and best occurs in a minority of inflamed fetuses. FVS has been suggested to complicate maternal chickenpox as early as three weeks 55 and as late as 28 weeks 56 of gestation. Pooled data from nine cohort studies detected 13 instances of FVS following 1423 instances of maternal chickenpox occurring earlier than 20 weeks of gestation, an occurrence of 0.91%.28 the danger seems to decrease within the first trimester (0. 55%). The cohort study identified one case of FVS taking place among about 180 women who advanced chickenpox between 20 and 28 weeks of gestation.28 In addition, this assessment recognized seven case reports of FVS following maternal contamination from 20 to 28 weeks and one wherein maternal contamination occurred at 28 weeks. These case reviews provide no denominators; therefore, the occurrence price for FVS following overdue second-trimester infection cannot be quoted, but they suggest that FVS is not confined to instances of maternal contamination before 20 weeks. The observational proof is offered in phase four.3 suggests that publish-exposure prophylaxis in inclined pregnant women reduces the risk of developing FVS.
Varicella infection of the newborn (formerly referred to as congenital varicella) refers to VZV infection in the early neonatal period due to a maternal infection close to the time of transport or immediately postpartum or contact with a person aside from the mother with chickenpox or shingles at some point in time. The course of infection will be Trans placental, ascending vaginal, or result from direct contact with lesions at some stage during or after delivery. If maternal contamination occurs 1–four weeks before shipping, as much as 50% of infants are inflamed and approximately 23% broaden scientific varicella, regardless of high titers of passively received maternal antibodies. Intense chickenpox is most likely to arise if the infant is born within 7 days of the onset of the mother’s rash, or if the mother develops a rash up to 7 days after shipping. For babies born to mothers who have chickenpox within the period 7 days before to 7 days after transport, the neonate must receive prophylaxis as quickly as feasible with VZIG, with or without acyclovir; there may be no need to test in those instances.
Girls with chickenpox ought to breastfeed if they want to, and are sufficiently good to achieve this. If there are active chickenpox lesions near the nipple, they should express breast milk from the affected breast until the lesions have crusted. The expressed breast milk may be fed to a baby who is receiving remedies with VZIG and/or acyclovir.
Research Method
To research the topic of chickenpox in pregnancy and its associated dangers, headaches, and management, a comprehensive literature review and evaluation of applicable studies have been performed. The research involved searching instructional databases, medical journals, and professional resources for peer- reviewed articles, medical trials, case research, and professional pointers published up until the know-how cutoff in September 2021. The key phrases used for the search protected "chickenpox in pregnancy," "varicella in pregnancy," "maternal headaches," "fetal complications," "preventive measures," and "remedy options."Result
The research yielded a large body of literature on chickenpox in pregnant women, highlighting the potential risks and complications for each pregnant woman and her fetus. The findings have been labeled into the subsequent key regions:
Maternal complications:
Research continually shows thatpregnant women with chickenpox are at a better risk of experiencing extreme symptoms compared to non-pregnant individuals. Pneumonia and encephalitis were among the most common complications observed in pregnant girls inflamed with the varicella-zoster virus. The chance of excessive headaches is regarded as being especially high in girls who have been infected early in pregnancy.
Fetal complications:
The hazard of congenital varicella syndrome turned out to be great, and the contamination occurred during the first 20 weeks of pregnancy. This syndrome can result in diverse birth defects and developmental troubles in the fetus. However, the chance of fetal complications decreased when the maternal infection occurred later in pregnancy.
Preventive Measures:
The research emphasized the significance of vaccination because the best preventive measure against chickenpox is being pregnant. Vaccination before pregnancy protects women from infection at some point in their gestation. Moreover, the administration of varicella-zoster immune globulin (VZIG) to exposed pregnant ladies can lessen the severity of the sickness if given within a certain time frame.
Control and remedy:
Modern-day pointers on handling chickenpox in pregnancy by providing supportive care and treating signs and symptoms. Antiviral medicinal drugs, inclusive of acyclovir, had been taken into consideration in specific situations, although further studies were needed to determine their protection and efficacy in pregnant ladies.
Discussion
The findings of this research underscore the significance of know-how of the dangers and headaches related to chickenpox in pregnancy. Pregnant girls who agreement the varicella-zoster virus must be intently monitored for capability headaches, specifically if the infection occurs during the early degrees of pregnant. Preventive measures, which include vaccination before conception and well-timed management of VZIG while exposed to chickenpox, can help reduce the severity of the ailment.
Future research is warranted to address several gaps in know- how, including the long-term consequences for fetuses affected by maternal chickenpox infection and the safety and effectiveness of antiviral medicinal drugs in the course of pregnancy. Moreover, ongoing surveillance is vital to tune the impact of vaccination rules on decreasing the occurrence of chickenpox in pregnant girls and their fetuses.
Clinicians should live updated the modern-day guidelines and suggestions concerning chickenpox in pregnancy to provide ultimate care and management for pregnant ladies liable to or stricken by the contamination.
Conclusion
Chickenpox is a common formative illness; however, if it develops during pregnancy, it is associated with critical destructive sequelae, including congenital varicella syndrome, maternal VZV pneumonia, and neonatal varicella infection, which may also lead to feto-maternal morbidity and mortality. Vaccination towards VZV is to be had but is not presently blanketed within the preferred youth immunization packages or mechanically endorsed for non-immune adult women in the United Kingdom. Prevention techniques must also encompass plans for managing public incidents. When chickenpox occurs during pregnancy, an antiviral remedy, either alone or in combination with VZIG, is recommended for management. The use of antivirals decreases the risk of mortality and morbidity due to chickenpox; however, this can occur. VZIG reduces the occurrence and severity of chickenpox but no longer does away with them, and is of no benefit as soon as signs of chickenpox come to be obvious. The situation of pregnant girls with a history of contact with an index issue with chickenpox, either arriving at a public medical institution or telephoning for a recommendation, merits each obstetric unit with a written protocol to lessen useless expenses, while providing the best protection for those most liable to unfavorable sequelae.
Acknowledgement
The completion of this research project would not have been possible Without the contributions and support of many individuals and organizations. We are deeply grateful to all those who played a role in the success of this project I would like to thank My Mentor [Dr. Naweed Imam Syed Prof. Department of Cell Biology at the University of Calgary for their invaluable input and support throughout the research process. Their insights and expertise were instrumental in shaping the direction for this project.
Funding No Funding Conflict of Interest The authors declare no conflict of interest
References
- Public Health England. Varicella: The Green Book, Chapter 34. London: Public Health England, 2012. Available from: https://www.gov.uk/government/publications/varicella-the- green-book-chapter-34.
- Sharland, M., A. Cant, E. G. Davies, D. A. Elliman, S. Esposito, et al. "Chicken Pox—Varicella Zoster." Manual of Childhood Infections. The Blue Book (2011): 467-74.
- Vyse, A. J., Gay, N. J., Hesketh, L. M., Morgan-Capner, P., & Miller, E. (2004). Seroprevalence of antibody to varicella zoster virus in England and Wales in children and young adults. Epidemiology & Infection, 132(6), 1129-1134.
- Plans, P., Costa, J., Espuñes, J., Plasència, A., & Salleras,L. (2007). Prevalence of varicella-zoster antibodies inpregnant women in Catalonia (Spain). Rationale for varicella vaccination of women of childbearing age. BJOG: An International Journal of Obstetrics & Gynaecology, 114(9), 1122-1127.
- Saadatian-Elahi, M., Mekki, Y., Del Signore, C., Lina, B., Derrough, T., Caulin, E., ... & Vanhems, P. (2007). Seroprevalence of varicella antibodies among pregnant women in Lyon-France. European journal of epidemiology, 22, 405-409.
- Miller, E., Marshall, R., & Vurdien, J. E. (1993). Epidemiology, outcome and control of varicella-zoster infection. Reviews and Research in Medical Microbiology, 4(4), 222-230.
- Lee. (1998). Review of varicella zoster seroepidemiology in India and South-east Asia. Tropical Medicine & International Health, 3(11), 886-890.
- Breuer, J. (2008). Herpes zoster: new insights provide an important wake-up call for management of nosocomial transmission. The Journal of Infectious Diseases, 197(5), 635-637.
- Scottish Intercollegiate Guidelines Network. SIGN 50: Guideline developer handbook. Edinburgh: SIGN; 2011. Available from: http://www.sign.ac.uk/pdf/sign50.pdf.
- McGregor, J. A., Mark, S., Crawford, G. P., & Levin, M.J. (1987). Varicella zoster antibody testing in the care of pregnant women exposed to varicella. American journal of obstetrics and gynecology, 157(2), 281-284.
- Health Protection Agency Rash Guidance Working Group. (2011). Guidance on viral rash in pregnancy: investigation, diagnosis and management of viral rash illness, or exposure to viral rash illness, in pregnancy. Health Protection Agency, London.
- Cohen, A., Moschopoulos, P., Stiehm, R. E., & Koren,G. (2011). Congenital varicella syndrome: the evidence for secondary prevention with varicella-zoster immune globulin. CMAJ, 183(2), 204-208.
- Enders, G., & Miller, E. (2000). Varicella and herpes zoster in pregnancy and the newborn. Varicella-zoster virus: virology and clinical management, 317-347.
- Pastuszak, A. L., Levy, M., Schick, B., Zuber, C., Feldkamp, M., et al. (1994). Outcome after maternal varicella infection in the first 20 weeks of pregnancy. New England Journal of Medicine, 330(13), 901-905.
- Centers for Disease Control and Prevention. (1996). Prevention of varicella: recommendation of the Advisory Committee on Immunization Pediatrics (ACIP). MMWR Morb Mort Wkly Rep, 45, 1-36.
- Rawson, H., Crampin, A., & Noah, N. (2001). Deaths from chickenpox in England and Wales 1995-7: analysis of routine mortality data. Bmj, 323(7321), 1091-1093.
- Harger, J. H., Ernest, J. M., Thurnau, G. R., Moawad, A., Momirova, V., et al. National Institute of Child Health and Human Development, Network of Maternal-Fetal Medicine Units. (2002). Risk factors and outcome of varicella- zoster virus pneumonia in pregnant women. The Journal of infectious diseases, 185(4), 422-427.
- Tan, M. P., & Koren, G. (2006). Chickenpox in pregnancy: revisited. Reproductive Toxicology, 21(4), 410-420.
- Wallace MR, Bowler WA, Murray NB, Brodine SK,Oldfield EC III. Treatment of varicella with oral acyclovir. Randomized placebo-controlled trials. Ann Intern Med 1992;117:358–63.
- Stone, K. M., Reiff-Eldridge, R., White, A. D., Cordero, J. F., Brown, Z., et al. (2004). Pregnancy outcomes following systemic prenatal acyclovir exposure: conclusions from the international acyclovir pregnancy registry, 1984–1999. Birth Defects Research Part A: Clinical and Molecular Teratology, 70(4), 201-207.
- Pasternak, B., & Hviid, A. (2010). Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects. Jama, 304(8), 859- 866.
- Mills, J. L., & Carter, T. C. (2010). Acyclovir exposure and birth defects: an important advance, but more are needed. JAMA, 304(8), 905-906.
- Daley, A. J., Thorpe, S., & Garland, S. M. (2008). Varicella and the pregnant woman: prevention and management. Australian and New Zealand Journal of Obstetrics and Gynaecology, 48(1), 26-33.
- Lamont, R. F., Sobel, J. D., Carrington, D., Mazaki-Tovi, S., Kusanovic, J. P., et al. (2011). Varicella-zoster virus (chickenpox) infection in pregnancy. BJOG: An International Journal of Obstetrics & Gynaecology, 118(10), 1155-1162.
- Gardella, C., & Brown, Z. A. (2007). Managing varicella zoster infection in pregnancy. Cleveland Clinic journal of medicine, 74(4), 290.
- W Kempf, P Meylan, S Gerber, C Aebi, R Agosti et al. Swiss guidelines for the management of varicella-zoster virus infection. Swiss Med Wkly 2007;137:239–51.
- Shrim, A., Koren, G., Yudin, M. H., Farine, D., Gagnon, R., et al. (2012). Management of varicella infection (chickenpox) in pregnancy. Journal of Obstetrics and Gynaecology Canada, 34(3), 287-292.
- J Obstet Gynaecol Can 2012;34:287–92.
- Nathwani, D., Maclean, A., Conway, S., & Carrington, D. (1998). Varicella infections in pregnancy and the newborn: A review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study ofn Infection. Journal of Infection, 36, 59-71.
- Tunbridge, A. J., Breuer, J., & Jeffery, K. J. M. (2008). Chickenpox in adults–clinical management. Journal of infection, 57(2), 95-102.
- Daley, A. J., Thorpe, S., & Garland, S. M. (2008). Varicella and the pregnant woman: prevention and management. Australian and New Zealand Journal of Obstetrics and Gynaecology, 48(1), 26-33.
- Lamont, R. F., Sobel, J. D., Carrington, D., Mazaki-Tovi, S., Kusanovic, J. P., eet al. (2011). Varicellaâ?ÂÂzoster virus (chickenpox) infection in pregnancy. BJOG: An International Journal of Obstetrics & Gynaecology, 118(10), 1155-1162.
- Gardella, C., & Brown, Z. A. (2007). Managing varicella zoster infection in pregnancy. Cleveland Clinic journal of medicine, 74(4), 290.
- Agosti, R. (2007). Swiss recommendations for the management of varicella zoster virus infections. Swissmedical weekly, 137(1718), 239-251
- Shrim, A., Koren, G., Yudin, M. H., Farine, D., Gagnon, R., et al. (2012). Management of varicella infection (chickenpox) in pregnancy. Journal of Obstetrics and Gynaecology Canada, 34(3), 287-292.
- Nathwani, D., Maclean, A., Conway, S., & Carrington, D. (1998). Varicella infections in pregnancy and the newborn: A review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study ofn Infection. Journal of Infection, 36, 59-71.
- Miller, E., Cradock-Watson, T. E., & Ridehalgh, M. S. (1989). Outcome in newborn babies given anti-varicella- zoster immunoglobulin after perinatal maternal infection with varicella-zoster virus. The Lancet, 334(8659), 371-373.
- Enders, G., Bolley, I., Miller, E., Cradock-Watson, J., & Ridehalgh, M. (1994). Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. The Lancet, 343(8912), 1548-1551.
- Brown, N. W., Parsons, A. P. R., & Kam, P. C. A. (2003).Anaesthetic considerations in a parturient with varicella presenting for Caesarean section. Anaesthesia, 58(11), 1092-1095.
- Enders, G., Bolley, I., Miller, E., Cradock-Watson, J., & Ridehalgh, M. (1994). Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. The Lancet, 343(8912), 1548-1551.
